NCT03490916

Effect of Acetazolamide on Subclinical High-Altitude Pulmonary Edema Detected by Lung Ultrasonography

A Prospective, Double-blind, Randomized, Placebo-controlled Trial of Acetazolamide on Subclinical High-Altitude Pulmonary Edema Detected by Lung Ultrasonography

• Status: Terminated
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 18 (actual)
• Sponsor: Vincent Kan · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The overall goal of this study is to detect preclinical signs of HAPE by lung ultrasonography and evaluate the effectiveness of acetazolamide at decreasing pulmonary edema by using ultrasound.

Conditions

• High Altitude Pulmonary Edema

Interventions

Type	Name	Description
DRUG	Acetazolamide	Administration of Acetazolamide
DRUG	Placebo	Administration of Placebo

Timeline

• Start date: 2018-03-23
• Primary completion: 2018-04-04
• Completion: 2018-04-04
• First posted: 2018-04-06
• Last updated: 2019-05-10
• Results posted: 2019-05-10

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study